{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:35:23Z","timestamp":1792092923848,"version":"4.4.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Medulloblastoma is the most common malignant central nervous system tumor in pediatric patients and is relatively rare in adults. Despite remarkable improvement in survival over recent decades, the high success rates in management documented in the Western world are not mirrored in middle- and low-income countries, due to various socio-economic factors and health-care disparities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of this study was to assess surgical treatment outcome and prognostic factors in operated patients with medulloblastoma in Tikur Anbessa Specialized Hospital and Myungsung Christian Medical Center, the 2 largest neurosurgical units in Ethiopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study involved 27 patients (21 children and 6 adolescent or young adults) who underwent surgery for medulloblastoma between January 2010 and April 2018.\u00a0A structured questionnaire was used to collect patients\u2019 data and their treatment outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>the 6 months and 1-year overall survival (OS) were 41% and 29% respectively, with a median survival time of 107 days (95% CI: 49,166). Median OS was 66 days (95% CI: 27,105), with 6 months and one-year OS rate of 24% for pediatric patients. Younger age at presentation, postoperative open EVD, longer Intensive Care Unit stay, lack of radiation treatment &amp;amp; postoperative complications were negative predictors of outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This experience underscores the high number of undiagnosed patients with medulloblastoma in Ethiopia and the poor outcome of patients who undergo active treatment. Standardization of treatment with surgery, craniospinal irradiation \u00b1 chemotherapy yields longer survival rates in both pediatric and adult patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2025.1672757","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:21:50Z","timestamp":1762147310000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Surgical management and outcome of medulloblastoma patients at Addis Ababa between 2010 and 2018"],"prefix":"10.3389","volume":"15","author":[{"given":"Yemisirach B.","family":"Akililu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bouffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mersha","family":"Abebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.02730","article-title":"Children\u2019s oncology group phase III trial of reduced-dose and reduced-volume radiotherapy with chemotherapy for newly diagnosed average-risk medulloblastoma","volume":"39","author":"Michalski","year":"2021","journal-title":"J Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1001\/jamaoncol.2021.2224","article-title":"Efficacy of carboplatin and isotretinoin in children with high-risk medulloblastoma","volume":"7","author":"Leary","year":"2021","journal-title":"JAMA Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdaf086","article-title":"Outcomes of pediatric medulloblastoma in low- and middle-income countries: A retrospective analysis of 335 cases from 8 countries","volume":"7","author":"Diaz-Coronado","year":"2025","journal-title":"Neuro-Oncology Adv"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1186\/s12885-023-11765-7","article-title":"Incidence and pattern of childhood cancer in Addis Ababa, Ethiopia, (2012\u20132017)","volume":"23","author":"Belay","year":"2023","journal-title":"BMC Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4314\/ejpch.v17i1.4","article-title":"A-5-year analysis of pediatric brain tumors in a tertiary care center, in a sub-saharan African country","volume":"17","author":"Balcha","year":"2022","journal-title":"Ethiopian J Pediatr Child Health"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200004000-00043","article-title":"Relationship of illness severity and length of stay to functional outcomes in the pediatric intensive care unit: A multi-institutional study","volume":"28","author":"Fiser","year":"2000","journal-title":"Crit Care Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw4892","article-title":"Science and health for all children with cancer","volume":"363","author":"Lam","year":"2019","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2019.05.018","article-title":"Comparison of epidemiology and outcomes in neuro-oncology between the east and the west: challenges and opportunities","volume":"31","author":"Gupta","year":"2019","journal-title":"Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70207-3","article-title":"Presentation of childhood CNS tumours: a systematic review and meta-analysis","volume":"8","author":"Wilne","year":"2007","journal-title":"Lancet Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.11.012","article-title":"A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma","volume":"48","author":"Gerber","year":"2012","journal-title":"Eur J Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov187","article-title":"A new clinical guideline from the Royal College of Paediatrics and Child Health with a national awareness campaign accelerates brain tumor diagnosis in UK children\u2014\u201cHeadSmart: Be Brain Tumour Aware","volume":"18","year":"2016","journal-title":"Neuro-Oncology"},{"key":"B12","article-title":"Headsmart Jordan: the impact of an hour of zoom lecture about pediatric brain tumors symptomatology on the knowledge of the health care providers","volume":"68","author":"Amayiri","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-024-04664-9","article-title":"Pediatric neurosurgical medulloblastoma outcomes in La Paz, Bolivia: How a Lower Middle-Income Country (LMIC) institution in South America compares to the United States","volume":"168","author":"Lu","year":"2024","journal-title":"J Neuro-Oncology"},{"key":"B14","article-title":"Use of ultrasonic aspirator for CNS tumour resection","volume":"71","author":"Ahmed","year":"2021","journal-title":"J Pakistan Med Assoc"},{"key":"B15","doi-asserted-by":"publisher","first-page":"100912","DOI":"10.1016\/j.bas.2022.100912","article-title":"Surgical outcomes of pediatric brain tumors in Sub-Saharan Africa: A systematic review","volume":"2","author":"Herdell","year":"2022","journal-title":"Brain Spine"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-021-05080-4","article-title":"Conduct of neuro-oncology multidisciplinary team meetings and closing the \u201cgaps\u201d in the clinical management of childhood central nervous system tumors in a middle-income country","volume":"37","author":"Foo","year":"2021","journal-title":"Child\u2019s Nervous System"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11833","article-title":"Children, cancer, and nutrition\u2014A dynamic triangle in review","volume":"100","author":"Sala","year":"2004","journal-title":"Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.8719","article-title":"Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial","volume":"30","author":"Lannering","year":"2012","journal-title":"J Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25313","article-title":"SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settings","volume":"62","author":"Parkes","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-016-2202-1","article-title":"Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study","volume":"129","author":"Sabel","year":"2016","journal-title":"J Neuro-Oncology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00969","article-title":"Late morbidity and mortality among medulloblastoma survivors diagnosed across three decades: A report from the childhood cancer survivor study","volume":"37","author":"Salloum","year":"2019","journal-title":"J Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29838","article-title":"How do we approach the management of medulloblastoma in young children","volume":"69","author":"Lafay-Cousin","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-025-05040-x","article-title":"Patterns, clinical presentations, and time to diagnosis in pediatric central nervous system tumors: insights from a pediatric neuro-oncology tumor board team at a tertiary referral hospital in Ethiopia","volume":"174","author":"Arega","year":"2025","journal-title":"J Neuro-Oncology"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1672757\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:21:51Z","timestamp":1762147311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1672757\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":23,"alternative-id":["10.3389\/fonc.2025.1672757"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1672757","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"article-number":"1672757"}}